New early breast cancer option recommended by NICE
The drug is recommended provided that Herceptin (trastuzumab) is the only HER2-directed adjuvant treatment people have had.
Read More
Tag: Nerlynx
Five new medicines backed for EU approval
Five therapies have been backed for approval in the European Union, including two orphan medicines addressing rare conditions.
Read More
US OK’s Puma’s new breast cancer therapy
Puma Biotechnology’s experimental breast cancer therapy Nerlynx has been issued a green light by the US Food and Drug Administration.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
